Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
PremiumPress ReleasesSentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
5M ago
Eiger Biopharmaceuticals CFO Exits Amid Bankruptcy Reorganization
Premium
Company Announcements
Eiger Biopharmaceuticals CFO Exits Amid Bankruptcy Reorganization
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100